VICTORINE ANZICK: Open Payments
NPI 1063066678 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 7 payments from 7 companies in 2025. Trend: 2023 $216 · 2024 $0 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| GENZYME CORPORATION | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Exeltis, USA Inc. | 1 | $103 |
Products named: AUSTEDO XR, TZIELD, JARDIANCE, FABRAZYME, AMVUTTRA, TWIRLA.
Industry payments across TX — which companies pay providers there.
